|本期目录/Table of Contents|

[1]朱 云,张南征,马文青,等.根除幽门螺杆菌对降低部队官兵消化性溃疡复发率的价值[J].医学研究与战创伤救治(原医学研究生学报),2011,13(04):294-296.
　ZHU Yun,ZHANG Nan-zheng,MA Wen-qing,et al.The study on the reduction of the peptic ulcers recurrence rate in soldiers after H.pylori eradication[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(04):294-296.
点击复制

根除幽门螺杆菌对降低部队官兵消化性溃疡复发率的价值()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第13卷
期数:
2011年04期
页码:
294-296
栏目:
出版日期:
2011-07-20

文章信息/Info

Title:
The study on the reduction of the peptic ulcers recurrence rate in soldiers after H.pylori eradication
文章编号:
1672-271X(2011)04-0294-03
作者:
朱 云; 张南征; 马文青; 江兴松; 戴 英; 马晓春; 邵艾俐; 封安强
221004 江苏徐州，解放军97医院消化内科
Author(s):
ZHU Yun; ZHANG Nan-zheng; MA Wen-qing; JIANG Xing-song; DAI Ying; MA Xiao-chun; SHAO Ai-li; FENG An-qiang.
Department of Gastroenterology,97 Hospital of PLA,Xuzhou,Jiangsu 221004,China
关键词:
消化性溃疡; 幽门螺杆菌; 复发率; 补救治疗
Keywords:
peptic ulcer;  Helicobacter pylori;  recurrence rate;  remedial therapy
分类号:
R573.1
DOI:
-
文献标志码:
A
摘要:
目的 探讨根除幽门螺杆菌(Hp)与降低消化性溃疡(PU)复发的相关性，确定适合于部队的根除HP治疗方案。方法 对照组为957例未接受规范抗Hp治疗的军人PU患者；治疗组为1371例Hp阳性的军人PU患者，采用奥美拉唑联合呋喃唑酮和甲硝唑方案治疗；对部分未达根除者，76例采用补救方案Ⅰ(奥美拉唑联合阿莫西林和呋喃唑酮)、65例采用补救方案Ⅱ(奥美拉唑联合左氧氟沙星和阿莫西林)治疗。观察两组的溃疡复发率及各治疗方案的Hp 根除率。结果 治疗组溃疡愈合率较对照组明显提高(P<0.01)，溃疡复发率明显降低(P<0.01)。 一线方案及补救方案Ⅰ、Ⅱ之Hp 根除率分别为84.68%(1161/1371)、86.84%(66/76)、89.23%(58/65)，总Hp 根除率93.73%(1285/1371)。结论 根除Hp 可明显降低PU患者的复发率，以奥美拉唑联合呋喃唑酮和甲硝唑的治疗方案及补救治疗方案，疗效可靠，副作用小，价格低廉，适宜在部队中推广应用。
Abstract:
Objective To investigate the correlation between the eradication of the Hp and reduction of the PU recurrence.To determine the suitable therapy of the eradication of Hp and reduce the PU relapse in troops.Methods Army PU patients were divided into trial group (n=1371) and control group (n=957).Patients in the trial group received anti-Hp therapy which include the first-line therapy (omeprazole,furazolidone,metronidazole for 10 days) and remedial therapy (scheme one: omeprazole,amoxicillin,furazolidone and scheme two: omeprazole,levofloxacin,amoxicillin for 7 days).Patients in control group didnt receive regular anti-Hp therapy.Results The eradication rate of the first line therapy and remedial therapy scheme one and two were 84.68%,86.84%,and 89.23%,respectively.The eradication rate of all patients in the trial group was 93.7%.Compared with the control group,the ulcer cure rate improved obviously(P<0.01),the recurrence rate decreased significantly(P<0.01).Conclusion The eradication of Hp obviously decreases the rate of relapse.Omeprazole plus furazolidone and metronidazole as the first-line therapy and remedial therapy schemes in PU patients associated with Hp infection.It is effective,compliable,little side effects,cheap,appropriate for army extended using.

参考文献/References:

[1]阳惠湘，张桂英，邹益友，等.幽门螺杆菌根除后消化性溃疡复发[J].中华消化杂志，2002，22(6):378-379.
[2]胡伏莲.第三次全国幽门螺杆菌感染若干问题共识报告(2007，庐山)[J].现代消化及介入诊疗,2008,13(1):73-76.
[3]叶晓芬，蔡建庭.消化性溃疡复发的原因及防治策略[J].国际消化病杂志，2008，28(2):130-131,136.
[4]胡伏莲.《幽门螺杆菌感染若干问题共识意见》解读[J].中国医刊,2007,42(1):4-6.
[5]陈新谦.新编药物学[M].北京:人民卫生出版社，1998:90.
[6]苏秉忠.合理用药，提高幽门螺杆菌根除率[J].内蒙古医学杂志，2007,39(1):1-3.
[7]胡 林，刘 荃.幽门螺杆菌耐药性的研究进展[J].贵州医药，2009,33(10):952-956.
[8]胡伏莲.幽门螺杆菌耐药及其根除失败原因研究[J].中国医药导刊,2006,8(5):340-342，345.
[9]马春曦，彭国林，张晓云.新三联方案根除幽门螺杆菌的疗效观察[J].东南国防医药，2008，10(3):192-194.
[10]Saad RJ，Schoenfeld P，Kim HM，et al.Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection:a meta-analysis[J].Am J Gastroenterol，2006，101(3):488-496.
[11]Nista EC，Candelli M，Zocco MA，et al.Levofloxacin-based triple therapy in first-Line treatment for Helicobacter pylori eradication[J].Am J Gastroenterol,2006,101(9):1985-1990.

相似文献/References:

[1]舒荣文,顾佳云,孔庆军.枸橼酸铋雷尼替丁为基础治疗萎缩性胃炎患者Hp的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):27.
　SHU Rong-wen,GU Jia-yun,KONG Qing-jun..Observation of curative effect of ranitidine bismuth citrate based triple therapies for eradication of Helicobacter pylori infection in chronic atrophic gastritis patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(04):27.
[2]马文青,张南征,朱 云,等.某地军人消化性溃疡流行病学分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(03):206.
　MA Wen-qing,ZHANG Nan-zheng,ZHU Yun,et al.Epidemiological analysis of soldiers with peptic ulcer in a certain region[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(04):206.
[3]李志晋,詹丽英,马春曦,等.白细胞介素-4对幽门螺杆菌根除的影响[J].医学研究与战创伤救治(原医学研究生学报),2011,13(06):534.
[4]刘 冉,张世联,牟振云,等.牛乳中抗幽门螺杆菌特异性抗体的 间接ELISA法的建立[J].医学研究与战创伤救治(原医学研究生学报),2008,10(03):174.
　LIU Ran,ZHANG Shi-lian,MOU Zhen-yun,et al.Development of indirect enzyme-linked immunosorbent assay(ELISA) for detection of anti-Helicobacter pylori antibodies from bovine immune milk[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(04):174.
[5]马春曦,彭国林,张晓云.新三联方案根除幽门螺杆菌的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2008,10(03):192.
　MA Chun-xi,PENG Guo-lin,ZHANG Xiao-yun.Effect of levofloxacin, amoxicillin and omeprazole triad system as rescue therapy for Helicobacter pylori infection[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(04):192.
[6]龚谋春,方晓明,姚宁,等.幽门螺杆菌相关性胃腺癌中IL-37的表达及意义[J].医学研究与战创伤救治(原医学研究生学报),2017,19(02):153.[doi:10.3969/j.issn.1672-271X.2017.02.010]
　GONG Mou-chun,FANG Xiao-ming,YAO Ning,et al.IL-37 level in HP positive patients with gastric adenocarcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(04):153.[doi:10.3969/j.issn.1672-271X.2017.02.010]
[7]杨辛怡综述,季国忠审校.幽门螺杆菌感染的治疗方案[J].医学研究与战创伤救治(原医学研究生学报),2017,19(03):280.[doi:10.3969/j.issn.1672-271X.2017.03.015]
[8]张燕,岳玉林,张之烽,等.儿童幽门螺杆菌感染检测方法临床适用性分析[J].医学研究与战创伤救治(原医学研究生学报),2017,19(03):302.[doi:10.3969/j.issn.1672-271X.2017.03.020]
[9]王旦,罗菡子,王娜,等.江西九江地区健康人群体检幽门螺杆菌检测结果分析[J].医学研究与战创伤救治(原医学研究生学报),2017,19(06):592.[doi:10.3969/j.issn.1672-271X.2017.06.008]
　WANG Dan,LUO Han-zi,WANG Na,et al.The test results and analysis of Helicobacter pylori infection in the physical examination population in Jiangxi Jiujiang area[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(04):592.[doi:10.3969/j.issn.1672-271X.2017.06.008]
[10]蒋世烨综述,孙为豪审校.幽门螺杆菌感染和环氧化酶?2在胃癌发生中的作用研究进展[J].医学研究与战创伤救治(原医学研究生学报),2019,21(4):392.[doi:10.3969/j.issn.1672-271X.2019.04.013]
　JIANG Shi-ye reviewing,SUN Wei-hao checking.Research progression of Helicobacter pylori infection and cyclooxygenase-2 in gastric carcinogenesis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2019,21(04):392.[doi:10.3969/j.issn.1672-271X.2019.04.013]

备注/Memo

备注/Memo:
南京军区“十一五”医药卫生科研基金(06MA49)
更新日期/Last Update: 2011-07-20